A synthesis of (1S,2R)-1-amino-2-indanol (1), a key component of an HIV protease inhibitor, was accomplished through (R)-2-hydroxy-1-indanone ((R)-3), which was prepared by an intramolecular Friedel–Crafts acylation of (R)-2-acetoxy-3-phenylpropanoic acid readily available from d-(R)-phenylalanine. Alternatively, (R)-3 was obtained by an enzymatic resolution of (±)-2-acetoxy-1-indanone. Ketone (R)-3 was converted into 1 through an oxime formation and diastereoselective hydrogenation.
No takes yet. Share an insight, caveat, or question.
Kajiro et al. (1999) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: